Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis
NCT02630901
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
PRX003
OTHER:
Placebo
Sponsor
Prothena Biosciences Limited